740 results
·
121ms
·
Sources: EU EUDAMED, US FDA
NA
FDA UDI
STRYKER CORPORATION·07613327060225·Laser Bridge (for use with Straight Fire Laser)
NA
FDA UDI
STRYKER CORPORATION·07613327062878·Rigid Optical Forcep Adapter (Inner Sheath)
NA
FDA UDI
STRYKER CORPORATION·07613327060331·Bridge, Single Horn
NA
FDA UDI
STRYKER CORPORATION·07613327060324·Port Seal
NA
FDA UDI
STRYKER CORPORATION·07613327060362·Bladder Syringe Adapter for Cystoscope Sheath
NA
FDA UDI
STRYKER CORPORATION·07613327063738·Ellik Adapter Sheath (Inner)
NA
FDA UDI
STRYKER CORPORATION·07613327060348·Bladder Syringe Adapter, Inner Sheath
NA
FDA UDI
STRYKER CORPORATION·07613327063479·24 Fr. Standard Flow Resectoscope Sheath Adapter
NA
FDA UDI
STRYKER CORPORATION·07613327063769·Reusable Stopcock
NA
FDA UDI
STRYKER CORPORATION·07613327060317·Evaluation Bridge
NA
FDA UDI
STRYKER CORPORATION·07613327060386·Rigid Optical Forcep Adapter (Outer Sheath)
NA
FDA UDI
STRYKER CORPORATION·07613327063684·21 Fr. Visual Urethrotome, Working/Optical Bridge
Clear Guide CORE
FDA UDI
CLEAR GUIDE MEDICAL, INC.·B201CGCORE170·The device is intended as a computer platform t...
Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
FDA Pre-Market Approval
FDA Class 3
·INFORM HER2 Dual ISH DNA Probe Cocktail assays
Clear Guide CORE
FDA UDI
CLEAR GUIDE MEDICAL, INC.·B201CGCORE24MR0·The device is intended as a computer platform t...
Clear Guide CORE
FDA UDI
CLEAR GUIDE MEDICAL, INC.·B201CGCORE130·The device is intended as a computer platform t...
Clear Guide CORE
FDA UDI
CLEAR GUIDE MEDICAL, INC.·B201CGCORE240·The device is intended as a computer platform t...
Containment System, Laparoscopic Power Morcellation, With Instrument Port
FDA classification
FDA Class 2
·Containment System, Laparoscopic Power Morcellation, With Instrument Port
Assay, Genotyping, Hepatitis C Virus
FDA Pre-Market Approval
FDA Class 2
·ABBOTT REALTIME HCV GENOTYPE II, ABBOTT REALTIME HCV GENOTYPE II CONTROL KIT, URACIL-N-GLYCOSYLASE (UNG)
System, Test, Her-2/Neu, Ihc
FDA Pre-Market Approval
FDA Class 3
·PATHWAY HER-2/NEU (CLONE CD11) PRIMARY ANTIBODY